Synthesis of potent and selective nonzinc binding matrix metalloproteinase-13 inhibitors

被引:0
|
作者
Carroll, Jeffery N. [1 ]
Fletcher, Theresa R. [1 ]
Hamper, Bruce C. [1 ]
Scholten, Jeffrey A. [1 ]
Hanau, Cathleen E. [1 ]
Ruminski, Peter G. [1 ]
Rogers, Michael D. [1 ]
Grapperhaus, Margaret L. [2 ]
Massa, Mark A. [2 ]
Schmidt, Michelle A. [2 ]
Shieh, Huey S. [1 ]
Caspers, Nicole [2 ]
McDonald, Joseph [1 ]
Munie, Grace E. [2 ]
Messing, Dean M. [2 ]
Portolan, Silvia [2 ]
Sunyer, Teresa [2 ]
Schnute, Mark E. [1 ]
机构
[1] Pfizer Global Res & Dev, Dept Chem, St Louis, MO 63017 USA
[2] Pfizer Inc, Global Res & Dev, St Louis, MO 63017 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
62-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, YH
    Xiang, JS
    DiGrandi, MJ
    Du, XM
    Ipek, M
    Laakso, LM
    Li, JC
    Li, W
    Rush, TS
    Schmid, J
    Skotnicki, JS
    Tam, S
    Thomason, JR
    Wang, Q
    Levin, JI
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (24) : 6629 - 6644
  • [2] Potent, selective and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Hu, Yonghan
    DiGrandi, Martin J.
    Du, Xuemei
    Ipek, Manus
    Laakso, Leif M.
    Li, Jianchang
    Li, Wei
    Rush, Thomas S.
    Schmid, Jean
    Skotnicki, Jerauld S.
    Tam, Steve
    Thomason, Jennifer R.
    Xiang, Jason S.
    Wang, Qin
    Levin, Jeremy I.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2665 - U2666
  • [3] Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13
    Monovich, Lauren G.
    Tommasi, Ruben A.
    Fujimoto, Roger A.
    Blancuzzi, Vincent
    Clark, Kirk
    Cornell, Wendy D.
    Doti, Robert
    Doughty, John
    Fang, James
    Farley, David
    Fitt, John
    Ganu, Vishwas
    Goldberg, Ronald
    Goldstein, Robert
    Lavoie, Stacey
    Kulathila, Raviraj
    Macchia, William
    Parker, David T.
    Melton, Richard
    O'Byrne, Elizabeth
    Pastor, Gary
    Pellas, Theodore
    Quadros, Elizabeth
    Reel, Noela
    Roland, Dennis M.
    Sakane, Yumi
    Singh, Hem
    Skiles, Jerry
    Somers, Joseph
    Toscano, Karen
    Wigg, Andrew
    Zhou, Siyuan
    Zhu, Lijuan
    Shieh, Wen-Chung
    Xue, Song
    McQuire, Leslie W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3523 - 3538
  • [4] Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13
    Tommasi, Ruben A.
    Weiler, Sven
    McQuire, Leslie W.
    Rogel, Olivier
    Chambers, Mark
    Clark, Kirk
    Doughty, John
    Fang, James
    Ganu, Vishwas
    Grob, Jonathan
    Goldberg, Ronald
    Goldstein, Robert
    LaVoie, Stacey
    Kulathila, Raviraj
    Macchia, William
    Melton, Richard
    Springer, Clayton
    Walker, Marc
    Zhang, Jing
    Zhu, Lijuan
    Shultz, Michael
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (21) : 6440 - 6445
  • [5] Design of highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Schnute, Mark E.
    Ruminski, Peter G.
    Massa, Mark A.
    Strohbach, Joseph W.
    Hanau, Cathleen E.
    Schmidt, Michelle A.
    Shieh, Huey S.
    Caspers, Nicole
    Collins, Brandon
    Carroll, Jeffery N.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Scholten, Jeffrey A.
    Rogers, Michael D.
    Grapperhaus, Margaret L.
    Hitchcock, Jeff
    Collins, Joe
    McDonald, Joseph
    O'Brien, Patrick
    Munie, Grace E.
    Messing, Dean M.
    Portolan, Silvia
    Settle, Steven L.
    Nemirovskiy, Olga
    Vickery, Lillian
    Sunyer, Teresa
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [6] Discovery of highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis
    Scholten, Jeffrey A.
    O'Brian, Patrick M.
    Nahra, Joe
    Morris, Mark
    Roark, William H.
    Hanau, Cathleen E.
    Ruminski, Peter G.
    Fletcher, Theresa R.
    Hamper, Bruce C.
    Shieh, Huey S.
    Collins, Brandon
    McDonald, Joseph
    Rogers, Michael D.
    Carroll, Jeffery N.
    Johnson, Adam
    Munie, Grace E.
    Man, Chiu-Fai
    Settle, Steven L.
    Nemirovskiy, Olga
    Vickery, Lillian
    Agawal, Arun
    Sunyer, Teresa
    Schnute, Mark E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [7] Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
    Choi, Jun Yong
    Fuerst, Rita
    Knapinska, Anna M.
    Taylor, Alexander B.
    Smith, Lyndsay
    Cao, Xiaohang
    Hart, P. John
    Fields, Gregg B.
    Roush, William R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (13) : 5816 - 5825
  • [8] Design and synthesis of 2-oxo-imidazolidine-4-carboxylic acid hydroxyamides as potent matrix metalloproteinase-13 inhibitors
    Robinson, RP
    Laird, ER
    Donahue, KM
    Lopresti-Morrow, LL
    Mitchell, PG
    Reese, MR
    Reeves, LM
    Rouch, AI
    Stam, EJ
    Yocum, SA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (09) : 1211 - 1213
  • [9] Matrix metalloproteinase-13 inhibitor
    Lloyd, AW
    DRUG DISCOVERY TODAY, 2000, 5 (10) : 478 - 479
  • [10] Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents
    Xie, Xin-Wen
    Wan, Ren-Zhong
    Liu, Zhao-Peng
    CHEMMEDCHEM, 2017, 12 (15) : 1157 - 1168